Amy Burroughs
Chief Executive Officer at TERNS PHARMACEUTICALS, INC.
Net worth: 255 737 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Erin Quirk | M | 53 | 5 years | |
| David Fellows | M | 67 | 4 years | |
| Charles Semba | M | 64 |
Eluminex Biosciences Ltd.
 Eluminex Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Eluminex Biosciences Ltd. is a Chinese clinical-stage biotechnology company that focuses on the development and commercialization of innovative therapeutics for ophthalmic diseases. Eluminex's headquarters and research and development center are located in Biobay Industrial Park, with a US-subsidiary located in the area. The private company has developed a pipeline of next-generation protein therapeutics for retinal diseases, including age-related macular degeneration, macular edema, and diabetic retinopathy. The company is devoted to innovating the next generation of first-in-class or ocular therapeutics for vision-threatening or lifestyle-limiting ocular diseases. Eluminex has exclusively licensed rights for the development and commercialization of an investigational clinical-stage biosynthetic cornea derived from recombinant human collagen type III for the treatment of corneal blindness. | 4 years |
| Bryan Yoon | M | 46 | 4 years | |
| Faraz Ali | M | 51 | 6 years | |
| Deepak Srivastava | M | 57 | 8 years | |
| Ann Taylor | M | 67 | 3 years | |
| Catherine Stehman-Breen | M | 61 | 4 years | |
| Jill Quigley | F | 49 | 4 years | |
| Radhika Tripuraneni | M | 44 | 2 years | |
| June Lee | M | 58 | 3 years | |
| Karah Parschauer | F | 46 | 3 years | |
| Mark Vignola | M | 47 | 4 years | |
| Michelle Corral | F | - | - | |
| Jin Long Chen | M | 61 | 8 years | |
| Peter Thompson | M | 64 |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | 14 years |
| Robert Williams | M | 75 | 8 years | |
| Jeffrey Kindler | M | 68 | 4 years | |
| David Goeddel | M | 72 | 8 years | |
| Carl Gordon | M | 59 | 6 years | |
| Tanya Lewis | F | 53 | 1 years | |
| Hong Bo Lu | M | 53 | 4 years | |
| Jeffrey Walsh | M | 58 | 4 years | |
| Laura Shawver | M | 66 |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | 5 years |
| Whittemore Tingley | M | 56 | 6 years | |
| Jenna Urban | F | - | - | |
| Dominic Cundari | M | - | 2 years | |
| Jennifer Drimmer | F | - | 2 years | |
| Joanna Auch | F | - | 3 years | |
| Emil T. Kuriakose | M | 44 | 1 years | |
| Kee-Hong Kim | M | - | 6 years | |
| Leone Patterson | F | 61 | 3 years | |
| Justin Ng | M | - | - | |
| Jon Root | M | 64 |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | - |
| Melita Jung | F | 47 | - | |
| Satoshi Konagai | M | - |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | 3 years |
| Timothy Hoey | M | 65 | 7 years | |
| Matthew Jay Pollman | M | - | - | |
| John Diekman | M | 81 |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | - |
| Jeffrey R. Jasper | M | - | 2 years | |
| Sunita Sethi | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Harry W. Alcorn | M | 68 | 4 years | |
| Alfred Scheidegger | M | 67 |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | 3 years |
| Hikaru Saito | M | - |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | 2 years |
| Scott Harris | M | - |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | - |
| Kirsten Gruis | M | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 46 | 100.00% |
| China | 1 | 2.17% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Amy Burroughs
- Personal Network
